CrossRef Incidence, prevalence, and prognostic impact of sarcopenia on hepatic and cardiovascular outcomes in non-cirrhotic metabolic dysfunctionassociated steatotic liver disease Rishi Chowdhary, Manjeet Kumar Goyal, Megh Patel, Rahul Chowdhary, Kirti Arora, Varun Mehta, Akash Batta, Omesh Goyal, Ashita Rukmini Vuthaluru Frontiers in Epidemiology .2026;[Epub] CrossRef Liver steatosis and fibrosis in acromegaly patients with active and controlled disease: a scoping review Karol P
So, this once-daily injection had a significant reduction over the course of 16 weeks, about a 12-, 13- pound weight loss with reduction in a lot of the parameters that we care about
They observed that sKlotho levels differed significantly across ages, and sKlotho was inversely correlated with age in healthy subjects
There is a lot at stake for the public and Medicare beneficiaries